{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:00:42Z","timestamp":1792044042460,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ecl.2013.05.010","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T23:46:22Z","timestamp":1378338382000},"page":"477-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Neuropsychiatric Findings in Cushing Syndrome and Exogenous Glucocorticoid Administration"],"prefix":"10.1016","volume":"42","author":[{"given":"Monica N.","family":"Starkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2013.05.010_bib1","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archneurpsyc.1952.02320150016002","article-title":"Neuropsychiatric aspects of Cushing\u2019s syndrome","volume":"67","author":"Trethowan","year":"1952","journal-title":"AMA Arch Neurol Psychiatry"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-197009000-00003","article-title":"Cushing\u2019s disease as a psychosomatic disorder\u2014a report of 10 cases","volume":"49","author":"Gifford","year":"1970","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.ecl.2013.05.010_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archpsyc.1976.01770090029002","article-title":"Neuroendocrine regulation in depression. 1. Limbic system-adrenocortical dysfunction","volume":"33","author":"Carroll","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ecl.2013.05.010_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.136.2.120","article-title":"Cushing\u2019s syndrome: a psychiatric-study of 29 patients","volume":"136","author":"Cohen","year":"1980","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006842-198102000-00002","article-title":"Depressed mood and other psychiatric manifestations of Cushing syndrome\u2014relationship to hormone levels","volume":"43","author":"Starkman","year":"1981","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/155005947800900104","article-title":"EEG changes and serum cortisol levels in Cushing\u2019s syndrome","volume":"9","author":"Tucker","year":"1978","journal-title":"Clin Electroencephalogr"},{"issue":"12","key":"10.1016\/j.ecl.2013.05.010_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00005053-198012000-00008","article-title":"Neuropsychological deficits in Cushing\u2019s syndrome","volume":"168","author":"Whelan","year":"1980","journal-title":"J\u00a0Nerv Ment Dis"},{"issue":"2","key":"10.1016\/j.ecl.2013.05.010_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","article-title":"Neuropsychiatric manifestations of patients with Cushing\u2019s syndrome\u2014relationship to cortisol and adrenocorticotropic hormone levels","volume":"141","author":"Starkman","year":"1981","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.ecl.2013.05.010_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0033-3182(86)72657-1","article-title":"Correlation of bedside cognitive and neuropsychological tests in patients with Cushing\u2019s syndrome","volume":"27","author":"Starkman","year":"1986","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-1781(86)90096-X","article-title":"Cushing\u2019s syndrome after treatment\u2014changes in cortisol and ACTH levels, and amelioration of the depressive syndrome","volume":"19","author":"Starkman","year":"1986","journal-title":"Psychiatry Res"},{"issue":"9","key":"10.1016\/j.ecl.2013.05.010_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","article-title":"Hippocampal-formation volume, memory dysfunction, and cortisol-levels in patients with Cushing\u2019s syndrome","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.ecl.2013.05.010_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0306-4530(92)90020-8","article-title":"Discordant changes in plasma ACTH and beta-lipotropin beta-endorphin levels in Cushing\u2019s disease patients with depression","volume":"17","author":"Starkman","year":"1992","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.ecl.2013.05.010_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/sleep\/15.6.514","article-title":"Sleep architecture and sleep-apnea in patients with Cushing\u2019s disease","volume":"15","author":"Shipley","year":"1992","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.ecl.2013.05.010_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-3223(92)90017-T","article-title":"EEG sleep in Cushing\u2019s disease and Cushing\u2019s syndrome\u2014comparison with patients with major depressive disorder","volume":"32","author":"Shipley","year":"1992","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0022-3956(95)00017-Y","article-title":"The effect of elevated systemic cortisol levels on plasma catecholamines in Cushing\u2019s syndrome patients with and without depressed mood","volume":"29","author":"Cameron","year":"1995","journal-title":"J\u00a0Psychiatr Res"},{"issue":"7","key":"10.1016\/j.ecl.2013.05.010_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0306-4530(96)00021-2","article-title":"Immune regulation in Cushing's syndrome: relationship to hypothalamic-pituitary-adrenal axis hormones","volume":"21","author":"Kronfol","year":"1996","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.ecl.2013.05.010_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0006-3223(99)00203-6","article-title":"Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease","volume":"46","author":"Starkman","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.ecl.2013.05.010_bib19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00006842-200111000-00018","article-title":"Elevated cortisol levels in Cushing's disease are associated with cognitive decrements","volume":"63","author":"Starkman","year":"2001","journal-title":"Psychosom Med"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-3223(02)01750-X","article-title":"Improvement in learning associated with increase in hippocampal formation volume","volume":"53","author":"Starkman","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1355617707070051","article-title":"Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease","volume":"13","author":"Hook","year":"2007","journal-title":"J\u00a0Int Neuropsychol Soc"},{"issue":"1\u20133","key":"10.1016\/j.ecl.2013.05.010_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2006.11.007","article-title":"Improvement in mood and ideation associated with increase in right caudate volume","volume":"101","author":"Starkman","year":"2007","journal-title":"J\u00a0Affect Disord"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuropharm.2011.07.006","article-title":"Impact of chronic hypercortisolemia on affective processing","volume":"62","author":"Langenecker","year":"2012","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib24","first-page":"416","article-title":"Central nervous system and Cushing\u2019s syndrome","volume":"39","author":"Krieger","year":"1972","journal-title":"Mt Sinai J Med"},{"issue":"21","key":"10.1016\/j.ecl.2013.05.010_bib25","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM198505233122102","article-title":"Evidence for 2 subtypes of Cushing\u2019s disease based on\u00a0the analysis of episodic cortisol secretion","volume":"312","author":"Vancauter","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2013.05.010_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2007-1014405","article-title":"The psychiatric phenomenology of Cushing's disease","volume":"25","author":"Loosen","year":"1992","journal-title":"Pharmacopsychiatry"},{"issue":"8","key":"10.1016\/j.ecl.2013.05.010_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/ajp.142.8.911","article-title":"Diagnostic categorization of psychiatric disturbance in Cushing\u2019s syndrome","volume":"142","author":"Haskett","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00023210-200115050-00003","article-title":"Psychiatric disorders associated with Cushing's syndrome\u2014epidemiology, pathophysiology and treatment","volume":"15","author":"Sonino","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ecl.2013.05.010_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1192\/bjp.142.1.16","article-title":"Cushing\u2019s syndrome and depression\u2014a prospective-study of 26 patients","volume":"142","author":"Kelly","year":"1983","journal-title":"Br J Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.ecl.2013.05.010_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000182736","article-title":"Course of depression in Cushing\u2019s syndrome\u2014response to treatment and comparison with graves-disease","volume":"39","author":"Sonino","year":"1993","journal-title":"Horm Res"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib31","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S1355617700611037","article-title":"Cognitive decline in patients with Cushing's syndrome","volume":"6","author":"Forget","year":"2000","journal-title":"J\u00a0Int Neuropsychol Soc"},{"issue":"4","key":"10.1016\/j.ecl.2013.05.010_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0306-4530(92)90040-E","article-title":"The brain as a target for adrenocortical steroids\u2014cognitive implications","volume":"17","author":"Martignoni","year":"1992","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0404.1993.tb04075.x","article-title":"Memory impairment in Cushing\u2019s disease","volume":"87","author":"Mauri","year":"1993","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0889-8529(18)30087-2","article-title":"Cushing\u2019s syndrome from the patients perspective","volume":"23","author":"Gotch","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.ecl.2013.05.010_bib36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2265.2004.02118.x","article-title":"Long-term negative impact on quality of life in patients with successfully treated Cushing's disease","volume":"61","author":"Heald","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bandc.2009.02.013","article-title":"Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging","volume":"71","author":"Michaud","year":"2009","journal-title":"Brain Cogn"},{"issue":"9","key":"10.1016\/j.ecl.2013.05.010_bib38","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2013.05.010_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.2011-2231","article-title":"Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome","volume":"97","author":"Resmini","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2013.05.010_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ecl.2005.01.016","article-title":"Cognitive function and cerebral assessment in patients who have Cushing's syndrome","volume":"34","author":"Bourdeau","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.ecl.2013.05.010_bib41","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1017\/S0954579408000564","article-title":"Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of Cushing syndrome","volume":"20","author":"Maheu","year":"2008","journal-title":"Dev Psychopathol"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0306-4530(95)00031-3","article-title":"Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study","volume":"21","author":"Naber","year":"1996","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004714-200202000-00009","article-title":"Mood changes during prednisone bursts in outpatients with asthma","volume":"22","author":"Brown","year":"2002","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ecl.2013.05.010_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00005053-197904000-00006","article-title":"Presentation of the steroid psychoses","volume":"167","author":"Hall","year":"1979","journal-title":"J\u00a0Nerv Ment Dis"},{"issue":"10","key":"10.1016\/j.ecl.2013.05.010_bib45","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archpsyc.1990.01810220079010","article-title":"Prednisone effects on neurochemistry and behavior\u2014preliminary findings","volume":"47","author":"Wolkowitz","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.ecl.2013.05.010_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archpsyc.56.6.527","article-title":"Decreased memory performance in healthy humans induced by stress-level cortisol treatment","volume":"56","author":"Newcomer","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib47","first-page":"694","article-title":"Acute adverse reactions to prednisone in relation to dosage","volume":"13","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ecl.2013.05.010_bib48","first-page":"81","article-title":"Glucocorticoid medication, memory and\u00a0steroid psychosis in medical illness","volume":"vol. 823","author":"Wolkowitz","year":"1997"},{"key":"10.1016\/j.ecl.2013.05.010_bib49","first-page":"41","article-title":"Effects of glucocorticoids on mood, memory, and the hippocampus treatment and preventive therapy","volume":"vol. 1179","author":"Brown","year":"2009"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib50","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1440-1819.2009.02005.x","article-title":"Central nervous system effects of natural and synthetic glucocorticoids","volume":"63","author":"Fietta","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11060-012-0919-z","article-title":"Steroid psychosis: a review for neurosurgeons","volume":"109","author":"Ross","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.ecl.2013.05.010_bib52","doi-asserted-by":"crossref","unstructured":"Wolkowitz OM, Burke H, Epel ES, et al. Glucocorticoids mood, memory, and mechanisms. In: Judd LL, Sternberg EM, editors. Glucocorticoids and mood clinical manifestations, risk factors, and molecular mechanisms. 2009. p. 19\u201340.","DOI":"10.1111\/j.1749-6632.2009.04980.x"},{"issue":"2","key":"10.1016\/j.ecl.2013.05.010_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","article-title":"The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited","volume":"53","author":"Dubovsky","year":"2012","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1081-1206(10)61756-5","article-title":"Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales","volume":"92","author":"Bolanos","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0020-7489(89)90009-6","article-title":"Depression, somatization and steroid use in chronic obstructive pulmonary-disease","volume":"26","author":"Gift","year":"1989","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib56","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S1355617712001014","article-title":"Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease","volume":"19","author":"Mrakotsky","year":"2013","journal-title":"J\u00a0Int Neuropsychol Soc"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13554790701475468","article-title":"The \u201csteroid dementia syndrome\u201d: a possible model of human glucocorticoid neurotoxicity","volume":"13","author":"Wolkowitz","year":"2007","journal-title":"Neurocase"},{"issue":"3","key":"10.1016\/j.ecl.2013.05.010_bib58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/ajp.141.3.369","article-title":"Reversible steroid dementia in patients without steroid psychosis","volume":"141","author":"Varney","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.ecl.2013.05.010_bib59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jama.1979.03290360027021","article-title":"Lithium prophylaxis of corticotropin-induced psychosis","volume":"241","author":"Falk","year":"1979","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ecl.2013.05.010_bib60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/appi.psy.43.6.495","article-title":"Olanzapine treatment of corticosteroid-induced mood disorders","volume":"43","author":"Goldman","year":"2002","journal-title":"Psychosomatics"},{"issue":"2\u20133","key":"10.1016\/j.ecl.2013.05.010_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jad.2004.07.001","article-title":"An open-label trial of olanzapine for corticosteroid-induced mood symptoms","volume":"83","author":"Brown","year":"2004","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ecl.2013.05.010_bib62","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1749-6632.1995.tb31402.x","article-title":"Commonly used therapeutic doses of glucocorticoids impair explicit memory","volume":"761","author":"Keenan","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.ecl.2013.05.010_bib63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2003.09.010","article-title":"Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy","volume":"55","author":"Brown","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.ecl.2013.05.010_bib64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0306-4522(95)00256-I","article-title":"Stress-induced atrophy of apical dendrites of hippocampal CA3C neurons\u2014comparison of stressors","volume":"69","author":"Magarinos","year":"1995","journal-title":"Neuroscience"},{"issue":"38","key":"10.1016\/j.ecl.2013.05.010_bib65","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1073\/pnas.1110444108","article-title":"Glucocorticoids are critical regulators of dendritic spine development and plasticity in\u00a0vivo","volume":"108","author":"Liston","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852913000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852913000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:38:47Z","timestamp":1760175527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852913000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0889852913000492"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2013.05.010","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric Findings in Cushing Syndrome and Exogenous Glucocorticoid Administration","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2013.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}